Paradoxically, MAOB exhibits tumor-suppressive effects in endometrial cancer (40) and hepatocellular carcinoma (41), while its loss promotes renal (34, 42) and bladder cancer progression (43–45). Here, MAOB is linked to endometrial cancer.